Merck
Merck & Co., Inc.
Symbol: MRK
PO Box 100
One Merck Drive
Whitehouse Station, NJ
08889-0100
United States
Phone: 908-423-1000
Fax: 908-735-1253
Web Site: http://www.merck.com
Symbol: MRK
PO Box 100
One Merck Drive
Whitehouse Station, NJ
08889-0100
United States
Phone: 908-423-1000
Fax: 908-735-1253
Web Site: http://www.merck.com
BUSINESS SUMMARY
Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of
various products for human and animal health. It offers Singulair for the chronic
treatment of asthma, and relief of symptoms of allergic rhinitis; Cozaar/Hyzaar and
Vasotec for the treatment of hypertension/heart failure; Fosamax and Fosamax Plus D for
the treatment and prevention of osteoporosis; Zocor, an atherosclerosis product;
Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the
ophthalmological products; Proscar, an urology product for the treatment of symptomatic
benign prostate enlargement; Maxalt, an acute migraine product; and Propecia for the
treatment of male pattern hair loss. The company offers Varivax to prevent chickenpox;
M-M-R II, for the treatment of measles, mumps, and rubella; ProQuad, a pediatric
combination vaccine against measles, mumps, rubella, and varicella; Gardasil for the
prevention of cervical cancer and genital warts; Pneumovax for the prevention of
pneumococcal diseases; RotaTeq for the protection against rotavirus gastroenteritis in
infants and children; and Zostavax, a vaccine for the prevention of shingles. The
company has agreements with Neuromed Pharmaceuticals, Ltd. to research, develop,
and commercialize compounds for the treatment of pain and other neurological
disorders; NicOx S.A. for the development of new antihypertensive drugs; FoxHollow
Technologies, Inc. for atherosclerotic plaque analysis; and Ariad Pharmaceuticals, Inc. to
develop and commercialize AP23573, a mTOR inhibitor. The company markets its
products either directly or through joint ventures to drug wholesalers and retailers,
hospitals, government agencies, and managed health care providers, such as health
maintenance organizations and other institutions. The company was founded in 1891
and is headquartered in Whitehouse Station, New Jersey.
Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of
various products for human and animal health. It offers Singulair for the chronic
treatment of asthma, and relief of symptoms of allergic rhinitis; Cozaar/Hyzaar and
Vasotec for the treatment of hypertension/heart failure; Fosamax and Fosamax Plus D for
the treatment and prevention of osteoporosis; Zocor, an atherosclerosis product;
Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the
ophthalmological products; Proscar, an urology product for the treatment of symptomatic
benign prostate enlargement; Maxalt, an acute migraine product; and Propecia for the
treatment of male pattern hair loss. The company offers Varivax to prevent chickenpox;
M-M-R II, for the treatment of measles, mumps, and rubella; ProQuad, a pediatric
combination vaccine against measles, mumps, rubella, and varicella; Gardasil for the
prevention of cervical cancer and genital warts; Pneumovax for the prevention of
pneumococcal diseases; RotaTeq for the protection against rotavirus gastroenteritis in
infants and children; and Zostavax, a vaccine for the prevention of shingles. The
company has agreements with Neuromed Pharmaceuticals, Ltd. to research, develop,
and commercialize compounds for the treatment of pain and other neurological
disorders; NicOx S.A. for the development of new antihypertensive drugs; FoxHollow
Technologies, Inc. for atherosclerotic plaque analysis; and Ariad Pharmaceuticals, Inc. to
develop and commercialize AP23573, a mTOR inhibitor. The company markets its
products either directly or through joint ventures to drug wholesalers and retailers,
hospitals, government agencies, and managed health care providers, such as health
maintenance organizations and other institutions. The company was founded in 1891
and is headquartered in Whitehouse Station, New Jersey.
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
Stock Rating